Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113

NCT04070768

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Univeristy of Illinois Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details
Completed

Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea

NCT03288974

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Korea University Ansan Hospital Ansan, South Korea
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • Soonchunhyang University Hospital Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
View all 33 locations
View Trial Details
Completed

Study of Cemiplimab in Adults With Cervical Cancer

NCT03257267

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +11 more
Locations
  • Arizona Oncology Associates Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Irvine Orange, California, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 105 locations
View Trial Details

Related conditions